Industry Voices—How the Trump administration’s step therapy policy changes will affect Medicare Advantage plans

Last year, the Trump administration, Health and Human Services (HHS), and the Center for Medicare & Medicaid Services (CMS) announced proposed changes to Medicare. One specific change that went into effect at the beginning of 2019 is allowing Medicare Advantage (MA) plans to apply step therapy practices for medications that are covered under Medicare Part B.
Read more...

;